• Vertex Pharmaceuticals EPS for the quarter ending June 30, 2024 was $-13.92, a 495.45% decline year-over-year.
• Vertex Pharmaceuticals 2023 annual EPS was $13.89, a 8.35% increase from 2022.
• Vertex Pharmaceuticals 2022 annual EPS was $12.82, a 42.29% increase from 2021.
• Vertex Pharmaceuticals 2021 annual EPS was $9.01, a 12.44% decline from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.